Ron Schackmann is a Senior Scientist in Screening & Assay Technologies at Genmab since April 2022. Prior to this role, Ron served as a Scientist in Translational Research at Merus from September 2017 to April 2022. Ron's academic background includes a postdoctoral researcher position at Harvard Medical School from April 2014 to July 2017, supervised by J. S, and another postdoctoral researcher role at UMC Utrecht from September 2007 to March 2014, supervised by P. W. Ron began academic training as a PhD student at UMC Utrecht, focusing on the context-dependent roles of p120-catenin in breast cancer progression under the mentorship of Prof. R. Ron earned a Master's degree in Bio-Molecular Sciences from Vrije Universiteit Amsterdam in 2007.
This person is not in the org chart
This person is not in any teams
This person is not in any offices